You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 66 No. 2, February 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Observation
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Neurology
 •Neurology, Other
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Mirtazapine Use in Human Immunodeficiency Virus–Infected Patients With Progressive Multifocal Leukoencephalopathy

Deanna Cettomai, BS; Justin C. McArthur, MBBS, MPH

Arch Neurol. 2009;66(2):255-258. doi:10.1001/archneurol.2008.557

Background  An efficacious treatment is needed for human immunodeficiency virus (HIV)–infected and uninfected patients with progressive multifocal leukoencephalopathy (PML).

Objective  To report clinical and magnetic resonance imaging changes in response to mirtazapine treatment in HIV-positive patients with PML.

Design  Case series.

Setting  Outpatient neurology clinic.

Patients  Four HIV-positive patients with PML.

Interventions  Mirtazapine use, 15 mg nightly.

Main Outcome Measures  Neurologic examinations and cranial magnetic resonance imaging.

Results  Three patients demonstrated objective clinical improvement, and 1 patient showed improvement on magnetic resonance imaging. The patient who experienced the most significant clinical improvement was the patient who received mirtazapine therapy closest to PML symptom onset. Mirtazapine use was safe and well tolerated.

Conclusion  Mirtazapine use may offer some benefit as treatment or prophylaxis for PML in patients with HIV infection.


Author Affiliations: Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option
Ripellino et al.
BMJ Case Reports 2011;2011:bcr1120103549-bcr1120103549.
ABSTRACT | FULL TEXT  

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Schroder et al.
Arch Neurol 2010;67:1391-1394.
ABSTRACT | FULL TEXT  

Role of N-Linked Glycosylation of the 5-HT2A Receptor in JC Virus Infection
Maginnis et al.
J. Virol. 2010;84:9677-9684.
ABSTRACT | FULL TEXT  

Progressive Multifocal Leukoencephalopathy: What's New?
Focosi et al.
Neuroscientist 2010;16:308-323.
ABSTRACT  

Clinical vigilance for progressive multifocal leukoencephalopathy in the context of natalizumab use
Tornatore and Clifford
Mult Scler 2009;15:S16-S25.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.